ClinicalTrials.govpublic full text
Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer
triple negative breast neoplasms, triple negative breast cancer, breast neoplasms, breast cancer, brca1 mutation, brca2 mutation, brca mutation, brca-associated breast carcinoma, brca1 protein, brca2 protein, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 803486
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.